FY2018 Earnings Forecast for Catalent, Inc. (CTLT) Issued By William Blair
Catalent, Inc. (NASDAQ:CTLT) – Investment analysts at William Blair lowered their FY2018 earnings estimates for shares of Catalent in a research report issued on Tuesday. William Blair analyst J. Kreger now anticipates that the company will post earnings per share of $1.43 for the year, down from their previous estimate of $1.52. William Blair has a “Ourperform” rating on the stock. William Blair also issued estimates for Catalent’s Q4 2019 earnings at $0.62 EPS and FY2019 earnings at $1.63 EPS.
A number of other equities research analysts have also issued reports on the stock. Piper Jaffray Companies raised their price target on shares of Catalent from $45.00 to $50.00 and gave the stock an “overweight” rating in a report on Tuesday. Zacks Investment Research raised shares of Catalent from a “hold” rating to a “buy” rating and set a $48.00 price target on the stock in a report on Monday, November 6th. Needham & Company LLC reissued a “hold” rating on shares of Catalent in a report on Monday, October 23rd. BidaskClub raised shares of Catalent from a “hold” rating to a “buy” rating in a research report on Thursday, October 5th. Finally, ValuEngine cut shares of Catalent from a “buy” rating to a “hold” rating in a research report on Monday, October 2nd. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $42.11.
COPYRIGHT VIOLATION WARNING: “FY2018 Earnings Forecast for Catalent, Inc. (CTLT) Issued By William Blair” was posted by Watch List News and is owned by of Watch List News. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright & trademark legislation. The correct version of this report can be read at https://www.watchlistnews.com/fy2018-earnings-forecast-for-catalent-inc-ctlt-issued-by-william-blair/1695857.html.
Shares of Catalent (NASDAQ:CTLT) traded down $0.12 during trading on Friday, reaching $38.00. 1,035,900 shares of the company’s stock were exchanged, compared to its average volume of 919,399. Catalent has a 1-year low of $22.94 and a 1-year high of $43.39.
Catalent (NASDAQ:CTLT) last announced its quarterly earnings results on Monday, November 6th. The company reported $0.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.20 by $0.01. The business had revenue of $543.90 million for the quarter, compared to analyst estimates of $490.75 million. Catalent had a net margin of 10.02% and a return on equity of 36.29%. The company’s revenue was up 23.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.16 EPS.
In related news, SVP Christine Dolan sold 1,594 shares of Catalent stock in a transaction dated Tuesday, August 29th. The shares were sold at an average price of $38.75, for a total transaction of $61,767.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
A number of hedge funds and other institutional investors have recently modified their holdings of CTLT. Acrospire Investment Management LLC lifted its position in Catalent by 72.2% during the 2nd quarter. Acrospire Investment Management LLC now owns 3,100 shares of the company’s stock valued at $109,000 after acquiring an additional 1,300 shares during the period. Quantbot Technologies LP raised its holdings in Catalent by 110.7% in the second quarter. Quantbot Technologies LP now owns 3,434 shares of the company’s stock worth $120,000 after buying an additional 1,804 shares during the last quarter. Fortaleza Asset Management Inc. purchased a new position in Catalent in the third quarter worth about $164,000. PNC Financial Services Group Inc. raised its holdings in Catalent by 66.5% in the first quarter. PNC Financial Services Group Inc. now owns 6,070 shares of the company’s stock worth $173,000 after buying an additional 2,425 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Catalent by 12.5% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,043 shares of the company’s stock worth $177,000 after buying an additional 559 shares during the last quarter.
Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.
Receive News & Ratings for Catalent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.